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trols (p > 0.05). No statistically signiﬁcant difference were
detected between OP and control groups, but we detected a
moderately higher positivity in results of OP. It was detected
a signiﬁcant difference between all patient groups (patients
with NOP and OP) and control group (p < 0.05).
Conclusion: As a result, detection of high autoantibod-
ies in NOP regarding to our results suggested us, these
chronic long-lasting disease process together with their
immunoregulatory molecules may activate unknown autoim-
mune mechanisms of the host and lead to formation of
autoimmunity. We also suggest that the decrease of autoan-
tibodides in OP may be caused by the absence of antigenic
stimulus originated from hydatid cysts.
doi:10.1016/j.ijid.2010.02.2135
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Prevalence of intestinal parasitoses and factors related
in the population infant of the community Santa Bárbara,
Municipality Valley Guanape, State Anzoategui, Bolivarian
Republic of Venezuela
R. Martínez
Instituto de Medicina Tropical ¨Pedro Kourí¨, Ciudad
Habana, Cuba
Background: Intestinal parasitism affects mainly the
infant population, on a worldwide scale; it is assessed that
contributes the greatest number of infected among more
than 1000000 of people who every year is declared. The
objective was to determine the prevalence of intestinal par-
asitism in the infant population of the community Santa
Barbara and to identify some risk factors.
Methods: A prevalence study was conducted. Universe:
infant population from 0 to 14 years, including a total of 172.
The collection of the primary datum was carried out under
the total consent of the parents, who were interviewed, and
some general data and of epidemiological interest was also
gathered. Two stool samples were in addition collected by
spontaneous defecation to each child. This study was con-
ducted during the months from February to August 2008.
For the analysis of association among the variables there
were used the tests of comparison of proportions, and of
X2, being considered a level of statistical signiﬁcance when
p value was equal or less than 0.05. In order to establish the
strength of association among some variables, the Reason of
Prevalence was used, there was taken into account the 95%
conﬁdence interval (CI).
Results: A total of 89 children were parasitized, for a
prevalence of 51.7%, being the ages of 5-9 most affected
(52.8%), as well as the male sex (56.1%). The risk factors
associated with the intestinal parasite infection were water
consumption without boiling, PR = 2.91 [1,8—4.4], not hav-
ing in-house WC, (PR = 3.8 [1.61—6.31], the utilization of
the collective well as source of water supply (RP = 1.80 [1.1-
3.1] and the use of feeding-bottle, (PR = 3.85 [1.8—8.1]. The
symptom that most frequently we found was the abdominal
pain (43.8%), the parasite that predominated was Giardia
lamblia followed by Entamoeba histolytica.
Conclusion: The prevalence of intestinal parasitism in the
infant population of the community studied was high, being
corroborated a narrow relationship between the presence
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f parasites and some risk factors that predisposed to the
ntestinal parasitism.
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Department of Medicine, 10700, Thailand
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Background: Ivermectin and albendazole are effective
gainst strongyloidiasis. However the efﬁcacy and the most
ffective dosing regimen in immunocompromised patients
re to be determined.
Methods: A prospective randomized open study com-
ared a 7-day course of oral albendazole 800mg daily with
single dose (200mg/kg), or two single doses given 2 weeks
part of ivermectin in Thai patients with chronic strongy-
oidiasis. The primary end points were relief of symptoms (if
resent) and clearance of Strongyloides larvae from faeces
fter treatment and at one year follow up.
Results: 90 patients were included in the analysis (30,
1, and 29 patients in albendazole, single dose, and two-
ingle doses ivermectin group respectively). Only 3 patients
n this study did not have any underlying diseases. Diabetes
ellitus, SLE, nephrotic syndrome, hematologic malignancy,
olid tumor, and HIV infection were common underlying dis-
ases these patients. The median (range) duration of follow
p were 15 (2—62) weeks in albendazole group, 30 (2—59)
eeks in single dose ivermectin group, and 24 (2—61) weeks
n two single doses ivermectin group. Cure rates were 76.7%,
6.8% and 100% in albendazole, single dose oral ivermectin,
nd two single dose oral ivermectin respectively (P = 0.003)
n perprotocol analysis. No serious adverse event associated
ith treatment was found in all groups.
Conclusion: This study conﬁrms the superiority of iver-
ectin compared to high dose of albendazole for the
reatment of chronic strongyloidiasis in immunocompro-
ised patients. A single oral dose was as effective as two
ingle oral doses of ivermectin.
oi:10.1016/j.ijid.2010.02.2137
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iochemical and immunological characterization of the
hCBP30 protein from Entamoeba histolytica
. González ∗, A. Carabarin, L. Baylon-Pacheco, J.L.
osales-Encina
CINVESTAV-IPN, México, MexicoBackground: Entamoeba histolytica, is the causative
gent of the amoebiasis. The infection is asymptomatic, but
nly a few people develop complications such as amebic
iver abscess. During this event, E. histolytica trophozoites
